BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease


Greenpeace/FOE report on GM corn in Spain

This recent report makes claims about the impact of using GM maize in Spain, some of which differ from the findings of the report ‘The farm level impact of using Bt maize in Spain’ (2002) by Graham Brookes.

Interested parties should note that the Greenpeace/FOE report does not accurately reflect mainstream commercial experience of using Bt maize by Spanish farmers. 

The primary ‘claim’ in the report about the impact of using Bt technology on maize yields is that ‘there are no clear advantages of using Bt maize’ and that ‘some other non GM varieties give better yields’.  Although both of these statements are correct, within clearly defined and specific circumstances, neither statement is representative of the experiences of the majority of Bt maize farmers in Spain:  

Ø      The Greenpeace/FOE report evidence cited is based on small-scale crop trial data only, from one location in the region of Navarra.  It does not include commercial farmers and does not consider data from a number of regions.  The area planted to maize in Navarra is also very small relative to mainstream production regions (it accounts for about 3%-4% of the total Spanish maize area);

Ø      The location where the Navarra trials data is taken from generally suffers low incidence and frequency of corn borer problems.  Therefore it is not surprising that Bt crops trialed with conventional crops did not offer a clear yield advantage.  This variability in impact of Bt technology was documented in the Brookes report, which highlighted a clear link between Bt’s impact on yield and the level of corn borer problems suffered by individual farmers;

Ø      It is possible for conventional maize varieties to deliver higher yields than the Bt variety used in trials because many different factors determine yield in a particular variety.  These include the ability of the variety to adapt to the local growing conditions, moisture and temperature levels, soil conditions and use of inputs like fertilisers and crop protection products.  The presence, or absence, of the genetic modification for insect control is only one factor of influence.        

Evidence presented in the Brookes report was based on real, farm level data over a four year period (data from the equivalent of about 500 farms who plant about 15,000 hectares of maize, of which about 3,000-4,000 hectares were Bt maize).  It included farms in locations with high and low levels of corn borer problems and highlighted that the damage that corn borer can cause to yield varies by location, year, climatic factors, timing of planting, whether insecticides are used or not and timing of insecticide applications.  Hence the positive impact on yields of planting Bt maize varies.  In regions where high infestation levels are commonplace the benefit is an average 10% yield improvement where insecticide treatments were previously used and, 15% where insecticide treatments were not previously used.  Other research across a number of Spanish regions put the average yield improvement at an average of 6.3% (within a range of 2.9% to 12.9%) whilst in some areas of low/medium pest attack the average yield improvement over the last four years has been about 1%.

Overall, the farm level evidence available shows that the use of Bt maize meets the needs of, and provides benefits to, farmers in regions that suffer high/medium levels of corn borer infestation.

For further information contact Graham Brookes on 00 44 1303 840958

2 September 2003

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.